Literature DB >> 28821618

Region-specific protein misfolding cyclic amplification reproduces brain tropism of prion strains.

Nicolas Privat1,2,3, Etienne Levavasseur1,2,3, Serfildan Yildirim1,2,3, Samia Hannaoui1,2,3, Jean-Philippe Brandel1,2,3,4, Jean-Louis Laplanche5, Vincent Béringue6, Danielle Seilhean3,7, Stéphane Haïk8,2,3,4,7.   

Abstract

Human prion diseases such as Creutzfeldt-Jakob disease are transmissible brain proteinopathies, characterized by the accumulation of a misfolded isoform of the host cellular prion protein (PrP) in the brain. According to the prion model, prions are defined as proteinaceous infectious particles composed solely of this abnormal isoform of PrP (PrPSc). Even in the absence of genetic material, various prion strains can be propagated in experimental models. They can be distinguished by the pattern of disease they produce and especially by the localization of PrPSc deposits within the brain and the spongiform lesions they induce. The mechanisms involved in this strain-specific targeting of distinct brain regions still are a fundamental, unresolved question in prion research. To address this question, we exploited a prion conversion in vitro assay, protein misfolding cyclic amplification (PMCA), by using experimental scrapie and human prion strains as seeds and specific brain regions from mice and humans as substrates. We show here that region-specific PMCA in part reproduces the specific brain targeting observed in experimental, acquired, and sporadic Creutzfeldt-Jakob diseases. Furthermore, we provide evidence that, in addition to cellular prion protein, other region- and species-specific molecular factors influence the strain-dependent prion conversion process. This important step toward understanding prion strain propagation in the human brain may impact research on the molecular factors involved in protein misfolding and the development of ultrasensitive methods for diagnosing prion disease.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  PMCA; amyloid; neurodegenerative disease; prion; prion disease; protein aggregation; protein misfolding; regional targeting; strains

Mesh:

Substances:

Year:  2017        PMID: 28821618      PMCID: PMC5633130          DOI: 10.1074/jbc.M117.793646

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding.

Authors:  G P Saborio; B Permanne; C Soto
Journal:  Nature       Date:  2001-06-14       Impact factor: 49.962

2.  Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins.

Authors:  R J Kascsak; R Rubenstein; P A Merz; M Tonna-DeMasi; R Fersko; R I Carp; H M Wisniewski; H Diringer
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

3.  Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans.

Authors:  M R Scott; R Will; J Ironside; H O Nguyen; P Tremblay; S J DeArmond; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

4.  A new variant of prion disease.

Authors:  J Collinge; M Rossor
Journal:  Lancet       Date:  1996-04-06       Impact factor: 79.321

5.  Human prion strain selection in transgenic mice.

Authors:  Kurt Giles; David V Glidden; Smita Patel; Carsten Korth; Darlene Groth; Azucena Lemus; Stephen J DeArmond; Stanley B Prusiner
Journal:  Ann Neurol       Date:  2010-08       Impact factor: 10.422

6.  Prion propagation and toxicity occur in vitro with two-phase kinetics specific to strain and neuronal type.

Authors:  Samia Hannaoui; Layal Maatouk; Nicolas Privat; Etienne Levavasseur; Baptiste A Faucheux; Stéphane Haïk
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

7.  Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein.

Authors:  H Büeler; M Fischer; Y Lang; H Bluethmann; H P Lipp; S J DeArmond; S B Prusiner; M Aguet; C Weissmann
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

8.  Variant Creutzfeldt-Jakob disease in France and the United Kingdom: Evidence for the same agent strain.

Authors:  Jean-Philippe Brandel; Craig A Heath; Mark W Head; Etienne Levavasseur; Richard Knight; Jean-Louis Laplanche; Jan Pm Langeveld; James W Ironside; Jean-Jacques Hauw; Jan Mackenzie; Annick Alpérovitch; Robert G Will; Stéphane Haïk
Journal:  Ann Neurol       Date:  2009-03       Impact factor: 10.422

9.  Molecular model of prion transmission to humans.

Authors:  Michael Jones; Darren Wight; Rona Barron; Martin Jeffrey; Jean Manson; Christopher Prowse; James W Ironside; Mark W Head
Journal:  Emerg Infect Dis       Date:  2009-12       Impact factor: 6.883

10.  Prominent and persistent extraneural infection in human PrP transgenic mice infected with variant CJD.

Authors:  Vincent Béringue; Annick Le Dur; Philippe Tixador; Fabienne Reine; Laurence Lepourry; Armand Perret-Liaudet; Stéphane Haïk; Jean-Luc Vilotte; Michel Fontés; Hubert Laude
Journal:  PLoS One       Date:  2008-01-09       Impact factor: 3.240

View more
  3 in total

Review 1.  Prion Strains and Transmission Barrier Phenomena.

Authors:  Angélique Igel-Egalon; Vincent Béringue; Human Rezaei; Pierre Sibille
Journal:  Pathogens       Date:  2018-01-01

Review 2.  In vitro Modeling of Prion Strain Tropism.

Authors:  Etienne Levavasseur; Nicolas Privat; Stéphane Haïk
Journal:  Viruses       Date:  2019-03-09       Impact factor: 5.048

Review 3.  Understanding Prion Strains: Evidence from Studies of the Disease Forms Affecting Humans.

Authors:  Marcello Rossi; Simone Baiardi; Piero Parchi
Journal:  Viruses       Date:  2019-03-29       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.